Author(s)
Cox, JamesContributor(s)
Rosolowski, Tacey AnnKeywords
B: Institutional Processes; B: Institutional Mission and Values; B: Ethics; D: Ethics; A: Professional Values, Ethics, Purpose; C: Professional Practice ; C: The Professional at Work; A: The Administrator; D: Understanding Cancer, the History of Science, Cancer Research ; D: The History of Health Care, Patient Care;A: The Researcher; A: The Interview Subject's Story;
Full record
Show full item recordAbstract
Dr. Cox explains that, while in his residency at Penrose, he became interested in the issues involved when obtaining the collaboration of patients in a study. He then discusses informed consent at length, describing the issues involved and making reference to the Tuskegee syphilis case as a summary of the ethical issues at play. To demonstrate his ideas about informed consent, Dr. Cox describes a trial on cancer of the esophagus. While patients treated with radiation or surgery had some results, pairing chemotherapy with radiation therapy has such profound results that they “couldn’t ethically continue the trial.” Dr. Cox explains that the Data Safety Monitoring Committee makes recommendations to stop any trial that is not ethically sound. Dr. Cox talks about several cases in which trials were conducted without any informed consent, and talks about the ethical and philosophical issues involved. He notes that informed consent was not a prominent issue until the 1970s, though now Institutional Review Boards are “out of hand.”Date
January 4, 2013Type
Interview SegmentIdentifier
oai:cdm16333.contentdm.oclc.org:p16333coll1/782Cox_James_20130104_S00A
http://cdm16333.contentdm.oclc.org/cdm/ref/collection/p16333coll1/id/782